Literature DB >> 8223661

Computerised calculation of the true costs of antibiotic therapy.

J R Kerr1, J G Barr, E T Smyth.   

Abstract

A system for computerised calculation of the drug costs and hidden costs of antibiotic therapy is described. A previously developed method for costing antibiotic therapy was used to quantify hidden costs arising from intravenous administration, labour, serum antibiotic assays, monitoring of haematological and biochemical indices, and disposal of sharp instruments. These calculations were installed into a software system using spreadsheets (Microsoft Excel/Windows). Cost calculations were simplified as a result of automated calculation with centralised cost updating, a facility for new antibiotics, a facility for atypical regimens, availability to a number of users, password protection and a facility for multiple courses of intravenous antibiotic therapy.

Mesh:

Substances:

Year:  1993        PMID: 8223661     DOI: 10.1007/bf01973642

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

1.  Technique for calculation of the true costs of antibiotic therapy.

Authors:  J R Kerr; J G Barr; E T Smyth; J O'Hare
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

2.  Cost comparison of intravenous antibiotic administration.

Authors:  R J Plumridge
Journal:  Med J Aust       Date:  1990-11-05       Impact factor: 7.738

Review 3.  Antimicrobial therapy. Cost-benefit considerations.

Authors:  B J Guglielmo; G F Brooks
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

4.  What is the cost of nephrotoxicity associated with aminoglycosides?

Authors:  J M Eisenberg; H Koffer; H A Glick; M L Connell; L E Loss; G H Talbot; N H Shusterman; B L Strom
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

  4 in total
  3 in total

1.  Using pharmacoeconomics to assess the comparative value of antibacterials. A UK perspective.

Authors:  P Davey
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

2.  Defining criteria for the pharmacoeconomic evaluation of new oral cephalosporins.

Authors:  P G Davey; M Malek
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

3.  An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins.

Authors:  E T Smyth; J G Barr; C A O'Neill; G M Hogg
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.